Strategic Investment

GAMEE and Flashy Group are betting $35M in digital gold to revolutionize gaming rewards. A look into the 'Play-For-Gold' model and its ambitious future.

With a massive French state-guaranteed financing, Eutelsat is funding a new fleet of 340 Airbus satellites to secure OneWeb's future in the LEO race.

With co-founder Tony Ngai now Co-President and CTO, Efinix is scaling its unique FPGA technology to capture the explosive demand in the edge AI market.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

A new partnership aims to fill a crucial funding gap for mid-sized businesses with flexible capital, backed by veterans from Oaktree, Sixth Street, and Apollo.

A simple nasal spray could offer immediate, broad protection against the flu. New landmark studies show how this antibody-based shield could revolutionize prevention.

Once valued at $3.3B, the healthtech giant seeks Chapter 11 protection, a stark warning for the post-pandemic digital health industry.

roverIQ launches Ava, a PMS-integrated AI, to answer the 62% of calls hotels miss, targeting lost revenue and easing front desk staff burnout.

Resalis Therapeutics hires a key leader from a Novo Nordisk acquisition to steer its novel RNA therapy, which aims for fat loss without muscle waste.

Italian engineering giant TECNIMONT partners with Argent LNG on a groundbreaking 25 MTPA modular facility, aiming to reshape the global LNG landscape.

A new AAAHC-accredited surgery center in Tarzana offers advanced spine and joint care, reflecting a national trend toward safer, cost-effective procedures.

The investment firm diversifies from equities into regenerative organic U.S. farmland, using AI to boost yields and create a resilient new asset class.

Slingshot Aerospace's TALOS AI will create unpredictable, machine-speed adversaries, revolutionizing how Guardians prepare for orbital conflict.

Propanc Biopharma is taking a 100-year-old cancer treatment concept into modern human trials, targeting advanced tumors and expanding into fibrosis.

A landmark $1B DoD investment will spin off L3Harris's missile division into a public company, aiming to solve a critical rocket motor shortage.

Adimab's stellar 2025 reveals its crucial role as the hidden tech platform driving drug discovery for giants like Lilly and Regeneron.

A new partnership makes Eli Lilly's powerful AI models available to smaller firms via Revvity's platform, aiming to accelerate innovation with federated learning.

With key trials in brain and prostate cancer, Curasight heads to a top investor conference to showcase its dual-action theranostic technology.

SEALSQ appoints public-private partnership veteran Rolf Gobet to lead its new Geneva Quantum Center, a key move in a well-funded race against quantum threats.

With Sir Nick Clegg and AI pioneer Yann LeCun on board, HIRO Capital's new fund is a bold bet on Europe's ability to lead in deep tech innovation.